| This article has been cited by |
| 1 | Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis | |
| Dong Liu,Li-na Wang,Hong-xia Li,Ping Huang,Liang-bo Qu,Fei-yan Chen |
| Journal of International Medical Research.2017;45(2)383 |
| [DOI] |
|
| 2 | Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure | |
| Lingyu Xue,Zhanglei Pan,Qiao Yin,Peng Zhang,Jing Zhang,Wenwen Qi |
| International Urology and Nephrology.2019;51(12)2305 |
| [DOI] |
|
| 3 | Formulation and in vivo evaluation of aliskiren-loaded poly(lactic-co-glycolic) acid nanoparticles | |
| Derek E Murrell,Jessica M Coleman,Stacy D Brown,Sam Harirforoosh |
| Toxicology Research and Application.2018;2(12)239784731880115 |
| [DOI] |
|
| 4 | NONSPECIFIC MECHANISMS OF CHRONIC KIDNEY DISEASE PROGRESSION | |
| V. V. Kalyuzhin,O. I. Urazova,Ye. V. Kalyuzhina,O. F. Sibireva,L. M. Tkalich,L. I. Zibnitskaya,N. N. Terent’yeva |
| Bulletin of Siberian Medicine.2015;14(4)87 |
| [DOI] |
|
| 5 | Implications of miRNAs on TGF-ß/TAK1/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats | |
| Hekmat M. El Magdoub,Mona F. Schaalan,Rania M. Rahmo,Doaa B. Farag,Lobna H. Khedr |
| Toxicology and Applied Pharmacology.2020;404(4)115184 |
| [DOI] |
|
